- Edward Hall
- Eric Yoo
- Jean-Jacques Le Fur
- Khalid Deojee
- Olga Smolentseva
Healthcare: We believe investors are in for a wild ride, as the Biotech bear market rout appears here to stay.
HealthcareWe believe investors are in for a wild ride, as the Biotech bear market rout appears here to stay. We believe the key issues today are negative clinical news flow, lack of business development activity, and a funding gap that appears to have been affecting Biotech on a very top-down level. However irrespective of fundamentals record cash is on the sidelines at Big Pharma and VCs/PEs begging the question when the market has bottomed, and if we are going to pass through the eye of the storm, and have a more structural cyclical downturn, or if macro woes are overdone and we will return to fundamentals this year.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.